BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

544 related articles for article (PubMed ID: 16156145)

  • 21. Anatomic and functional outcome after 23-gauge vitrectomy, peeling, and intravitreal triamcinolone for idiopathic macular epiretinal membrane.
    Konstantinidis L; Berguiga M; Beknazar E; Wolfensberger TJ
    Retina; 2009 Sep; 29(8):1119-27. PubMed ID: 19734764
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pars plana vitrectomy with internal limiting membrane peeling for diabetic macular edema.
    Hartley KL; Smiddy WE; Flynn HW; Murray TG
    Retina; 2008 Mar; 28(3):410-9. PubMed ID: 18327132
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Surgical outcomes of epiretinal membranes associated with combined hamartoma of the retina and retinal pigment epithelium.
    Cohn AD; Quiram PA; Drenser KA; Trese MT; Capone A
    Retina; 2009 Jun; 29(6):825-30. PubMed ID: 19276871
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Management of vitreoretinal complications in eyes with permanent keratoprosthesis.
    Ray S; Khan BF; Dohlman CH; D'Amico DJ
    Arch Ophthalmol; 2002 May; 120(5):559-66. PubMed ID: 12003604
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Evaluation of results of combined pars plana vitrectomy and cataract removal].
    Wilczyński M; Pikulski Z; Dziegielewski K; Omulecki W
    Klin Oczna; 2005; 107(4-6):252-5. PubMed ID: 16118930
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pars plana vitrectomy for the management of retained lens material after cataract surgery.
    Merani R; Hunyor AP; Playfair TJ; Chang A; Gregory-Roberts J; Hunyor AB; Azar D; Cumming RG
    Am J Ophthalmol; 2007 Sep; 144(3):364-70. PubMed ID: 17632068
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Safety and efficacy of small incision, sutureless pars plana vitrectomy for patients with posterior segment complications secondary to uveitis.
    Androudi S; Praidou A; Symeonidis C; Tsironi E; Iaccheri B; Fiore T; Tsinopoulos I; Brazitikos P
    Acta Ophthalmol; 2012 Aug; 90(5):e409-10. PubMed ID: 22189086
    [No Abstract]   [Full Text] [Related]  

  • 28. Vitreoretinal surgery in Behçet's disease with severe ocular complications.
    Ozertürk Y; Bardak Y; Durmuş M
    Acta Ophthalmol Scand; 2001 Apr; 79(2):192-6. PubMed ID: 11284762
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pars plana vitrectomy. Vitrectomy treatment of vitreous opacities.
    Peyman GA; Huamonte FU; Goldberg MF
    Trans Sect Ophthalmol Am Acad Ophthalmol Otolaryngol; 1976; 81(3 Pt 1):394-8. PubMed ID: 960361
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Surgical outcomes for vitrectomy in Eales' disease.
    Shukla D; Kanungo S; Prasad NM; Kim R
    Eye (Lond); 2008 Jul; 22(7):900-4. PubMed ID: 17401324
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Results of vitreous surgery for posterior complications of chronic uveitis.
    Yu HG; Chung H
    Korean J Ophthalmol; 1994 Jun; 8(1):20-5. PubMed ID: 7933629
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Anatomical and visual outcomes after episcleral macular buckling compared with those after pars plana vitrectomy for retinal detachment caused by macular hole in highly myopic eyes.
    Ando F; Ohba N; Touura K; Hirose H
    Retina; 2007 Jan; 27(1):37-44. PubMed ID: 17218913
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Visual outcomes with 23-gauge transconjunctival sutureless vitrectomy.
    Tewari A; Shah GK; Fang A
    Retina; 2008 Feb; 28(2):258-62. PubMed ID: 18301031
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Surgical outcomes for patients who develop macular holes after pars plana vitrectomy.
    Kumagai K; Ogino N; Furukawa M; Larson E; Uemura A
    Am J Ophthalmol; 2008 Jun; 145(6):1077-80. PubMed ID: 18378210
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Efficacy of intravitreal triamcinolone acetonide in the visualization of the vitreous during pars plana vitrectomy].
    Mańkowska A; Rejdak R; Nowomiejska K; Zagórski Z
    Klin Oczna; 2006; 108(1-3):24-7. PubMed ID: 16883934
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Familial exudative vitreoretinopathy. Results of surgical management.
    Pendergast SD; Trese MT
    Ophthalmology; 1998 Jun; 105(6):1015-23. PubMed ID: 9627651
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of vitreoretinal surgery in maximizing treatment outcome following complications after proton therapy for uveal melanoma.
    Tran BK; Schalenbourg A; Bovey E; Zografos L; Wolfensberger TJ
    Retina; 2013 Oct; 33(9):1777-83. PubMed ID: 23792487
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immediate pars plana vitrectomy improves outcome in retained intravitreal lens fragments after phacoemulsification.
    Chen CL; Wang TY; Cheng JH; Tai MC; Lu DW; Chen JT
    Ophthalmologica; 2008; 222(4):277-83. PubMed ID: 18560248
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Surgical treatment of uveitis.
    Sikić J; Suić SP
    Coll Antropol; 2001; 25 Suppl():71-6. PubMed ID: 11817019
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Results of pars plana vitrectomy in Behçet's disease.
    Ozdemir O; Erkam N; Bakkaloglu A
    Ann Ophthalmol; 1988 Jan; 20(1):35, 38. PubMed ID: 3345059
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.